Logo image
Sign in
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
Journal article

Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

G. Bianchi, E. Czerwinski, A. Kenwright, A. Burdeska, Robert R. Recker and D. Felsenberg
Osteoporosis International, Vol.23(6), pp.1769-1778
2012
PMID: 21975558

Details